NCT02131220View on ClinicalTrials.gov

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2017

Conditions
Myocardial InfarctionPercutaneous Coronary InterventionThrombolytic Therapy
Interventions
DRUG

Prourokinase

20mg intracoronary bolus infusion using selective catheter during PCI

DRUG

Tirofiban

10ug/kg intracoronary bolus infusion using selective catheter during PCI

DRUG

normal saline

intracoronary bolus infusion using selective catheter during PCI

Trial Locations (1)

200032

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT02131220 - Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter